Antibodies (Basel, Switzerland)

Keyphrases

Publications

volume 13, number 3, 2024

Shunsuke Fujii, Takuhiro Uto, Hiroaki Hayashi, Waraporn Putalun, Seiichi Sakamoto, Hiroyuki Tanaka, Yukihiro Shoyama
Application of Monoclonal Antibodies against Naturally Occurring Bioactive Ingredients. Antibodies (Basel, Switzerland) 13 (3) (2024)
Audrey Kassardjian, Danton Ivanochko, Brian Barber, Arif Jetha, Jean-Philippe Julien
Humanization of Pan-HLA-DR mAb 44H10 Hinges on Critical Residues in the Antibody Framework. Antibodies (Basel, Switzerland) 13 (3) (2024)
Connor Frey, Mahyar Etminan
Adverse Events of PD-1, PD-L1, CTLA-4, and LAG-3 Immune Checkpoint Inhibitors: An Analysis of the FDA Adverse Events Database. Antibodies (Basel, Switzerland) 13 (3) (2024)
Cinthia Magalhães Rodolphi, Isabela Ferreira Soares, Ada da Silva Matos, Rodrigo Nunes Rodrigues-da-Silva, Marcelo Urbano Ferreira, Lilian Rose Pratt-Riccio, Paulo Renato Rivas Totino, Kézia Katiani Gorza Scopel, Josué da Costa Lima-Junior
Dynamics of IgM and IgG Antibody Response Profile against Linear B-Cell Epitopes from Exoerythrocytic (CelTOS and TRAP) and Erythrocytic (CyRPA) Phases of Plasmodium vivax : Follow-Up Study. Antibodies (Basel, Switzerland) 13 (3) (2024)
Afrin Bahauddin, Kyra Curtis, Jutatip Guptarak, Ruksana Huda
A Bead-Based Nonradioactive Immunoassay for Autoantibody Testing in a Mouse Model of Myasthenia Gravis. Antibodies (Basel, Switzerland) 13 (3) (2024)
Tonia L Conner, Pooja Vir, Eric D Laing, Ian J Stewart, Edward Mitre, Kathleen P Pratt
The Seraph 100 ® Microbind Affinity Blood Filter Does Not Alter Levels of Circulating or Mucosal Antibodies in Critical COVID-19 Patients. Antibodies (Basel, Switzerland) 13 (3) (2024)
Shunsuke Fujii, Takuhiro Uto, Hiroaki Hayashi, Waraporn Putalun, Seiichi Sakamoto, Hiroyuki Tanaka, Yukihiro Shoyama
Application of Monoclonal Antibodies against Naturally Occurring Bioactive Ingredients. Antibodies (Basel, Switzerland) 13 (3) (2024)
Natalia V Mesonzhnik, Anton Belushenko, Polina Novikova, Alexey Kukharenko, Mikhail Afonin
Enhanced N-Glycan Profiling of Therapeutic Monoclonal Antibodies through the Application of Upper-Hinge Middle-Up Level LC-HRMS Analysis. Antibodies (Basel, Switzerland) 13 (3) (2024)
Stephen Wilson Kpordze, Gideon Mutie Kikuvi, James Hungo Kimotho, Victor Atunga Mobegi
Development, Optimization and Evaluation of a Sensitive Enzyme-Linked Immunosorbent Assay (ELISA) Prototype for Detection of Chicken-Based IgY Polyclonal Antibodies against Toxins of D. polylepis Venom. Antibodies (Basel, Switzerland) 13 (3) (2024)
Connor Frey, Mahyar Etminan
Immune-Related Adverse Events Associated with Atezolizumab: Insights from Real-World Pharmacovigilance Data. Antibodies (Basel, Switzerland) 13 (3) (2024)
Giavanna Paterno, Brenda D Moore, Brach M Bell, Kimberly-Marie M Gorion, Yong Ran, Stefan Prokop, Todd E Golde, Benoit I Giasson
Novel Monoclonal Antibody Specific toward Amyloid-β Binds to a Unique Epitope within the N-Terminal Region. Antibodies (Basel, Switzerland) 13 (3) (2024)
Audrey Kassardjian, Danton Ivanochko, Brian Barber, Arif Jetha, Jean-Philippe Julien
Humanization of Pan-HLA-DR mAb 44H10 Hinges on Critical Residues in the Antibody Framework. Antibodies (Basel, Switzerland) 13 (3) (2024)
Giavanna Paterno, Brenda D Moore, Brach M Bell, Kimberly-Marie M Gorion, Yong Ran, Stefan Prokop, Todd E Golde, Benoit I Giasson
Novel Monoclonal Antibody Specific toward Amyloid-β Binds to a Unique Epitope within the N-Terminal Region. Antibodies (Basel, Switzerland) 13 (3) (2024)
Natalia V Mesonzhnik, Anton Belushenko, Polina Novikova, Alexey Kukharenko, Mikhail Afonin
Enhanced N-Glycan Profiling of Therapeutic Monoclonal Antibodies through the Application of Upper-Hinge Middle-Up Level LC-HRMS Analysis. Antibodies (Basel, Switzerland) 13 (3) (2024)
Avi Magid, Khetam Hussein, Halima Dabaja-Younis, Moran Szwarcwort-Cohen, Ronit Almog, Michal Mekel, Avi Weissman, Gila Hyams, Vardit Gepstein, Netanel A Horowitz, Hagar Cohen Saban, Jalal Tarabeia, Michael Halberthal, Yael Shachor-Meyouhas
Knowledge of the Serological Response to the Third BNT162b2 Vaccination May Influence Compliance of Healthcare Workers to Booster Dose. Antibodies (Basel, Switzerland) 13 (3) (2024)
Saleha Hafeez, Najam Us Sahar Sadaf Zaidi
Prevention of Blood Incompatibility Related Hemagglutination: Blocking of Antigen A on Red Blood Cells Using In Silico Designed Recombinant Anti-A scFv. Antibodies (Basel, Switzerland) 13 (3) (2024)
Vadim Jucaud
Allogeneic HLA Humoral Immunogenicity and the Prediction of Donor-Specific HLA Antibody Development. Antibodies (Basel, Switzerland) 13 (3) (2024)
Tsutomu Ishizuka, Kazuhiro Iwadoh, Hiroshi Kataoka, Junichi Hoshino, Kosaku Nitta, Hideki Ishida
Novel Flow Cytometry Method Detecting Complement C1q Bound to Blood Type A/B IgG Antibody for Preventing Severe Antibody-Mediated Rejection in ABO-Incompatible Kidney Transplantation. Antibodies (Basel, Switzerland) 13 (3) (2024)
Vadim Jucaud
Allogeneic HLA Humoral Immunogenicity and the Prediction of Donor-Specific HLA Antibody Development. Antibodies (Basel, Switzerland) 13 (3) (2024)
Marta Freitas Monteiro, Maria Papaserafeim, Matteo Andreani, Aline Réal, Athanasios Kouklas, Daniela Reis Galvão, Jörg Dieter Seebach, Gisella L Puga Yung
NK Cytotoxicity Mediated by NK-92 Cell Lines Expressing Combinations of Two Allelic Variants for FCGR3 . Antibodies (Basel, Switzerland) 13 (3) (2024)
Mokshada Kumar, Sravani Lanke, Alka Yadav, Mfonabasi Ette, Donald E Mager, Dhaval K Shah
Inter-Antibody Variability in the Clinical Pharmacokinetics of Monoclonal Antibodies Characterized Using Population Physiologically Based Pharmacokinetic Modeling. Antibodies (Basel, Switzerland) 13 (3) (2024)
Mokshada Kumar, Sravani Lanke, Alka Yadav, Mfonabasi Ette, Donald E Mager, Dhaval K Shah
Inter-Antibody Variability in the Clinical Pharmacokinetics of Monoclonal Antibodies Characterized Using Population Physiologically Based Pharmacokinetic Modeling. Antibodies (Basel, Switzerland) 13 (3) (2024)
Afrin Bahauddin, Kyra Curtis, Jutatip Guptarak, Ruksana Huda
A Bead-Based Nonradioactive Immunoassay for Autoantibody Testing in a Mouse Model of Myasthenia Gravis. Antibodies (Basel, Switzerland) 13 (3) (2024)
Bok-Nam Park, Young-Sil An, Su-Min Kim, Su-Jin Lee, Yong-Jin Park, Joon-Kee Yoon
177 Lu Anti-Angiogenic Radioimmunotherapy Targeting ATP Synthase in Gastric Cancer Model. Antibodies (Basel, Switzerland) 13 (3) (2024)
Monique Vogel, Engeroff Paul
A Comparison of Natural and Therapeutic Anti-IgE Antibodies. Antibodies (Basel, Switzerland) 13 (3) (2024)
Vadim Jucaud
Allogeneic HLA Humoral Immunogenicity and the Prediction of Donor-Specific HLA Antibody Development. Antibodies (Basel, Switzerland) 13 (3) (2024)
Stephen Wilson Kpordze, Gideon Mutie Kikuvi, James Hungo Kimotho, Victor Atunga Mobegi
Development, Optimization and Evaluation of a Sensitive Enzyme-Linked Immunosorbent Assay (ELISA) Prototype for Detection of Chicken-Based IgY Polyclonal Antibodies against Toxins of D. polylepis Venom. Antibodies (Basel, Switzerland) 13 (3) (2024)
Karismananda, Ammar Abdurrahman Hasyim, Akihiko Sakamoto, Kyouhei Yamagata, Kartika Hardianti Zainal, Desi Dwirosalia Ningsih Suparman, Ika Yustisia, Marhaen Hardjo, Syahrijuita Kadir, Mitsuhiro Iyori, Shigeto Yoshida, Yenni Yusuf
Long-Term Immunity against SARS-CoV-2 Wild-Type and Omicron XBB.1.5 in Indonesian Residents after Vaccination and Infection. Antibodies (Basel, Switzerland) 13 (3) (2024)
Felix Stader, Cong Liu, Abdallah Derbalah, Hiroshi Momiji, Xian Pan, Iain Gardner, Masoud Jamei, Armin Sepp
A Physiologically Based Pharmacokinetic Model Relates the Subcutaneous Bioavailability of Monoclonal Antibodies to the Saturation of FcRn-Mediated Recycling in Injection-Site-Draining Lymph Nodes. Antibodies (Basel, Switzerland) 13 (3) (2024)
Ge Yang, Shahryar Khoshtinat Nikkhoi, Hajar Owji, Geng Li, Mohammad Massumi, Jessica Cervelli, Venu Gopal Vandavasi, Arash Hatefi
A Novel Tetravalent Bispecific Immune Cell Engager Activates Natural Killer Cells to Kill Cancer Cells without Mediating Fratricide. Antibodies (Basel, Switzerland) 13 (3) (2024)
Saleha Hafeez, Najam Us Sahar Sadaf Zaidi
Prevention of Blood Incompatibility Related Hemagglutination: Blocking of Antigen A on Red Blood Cells Using In Silico Designed Recombinant Anti-A scFv. Antibodies (Basel, Switzerland) 13 (3) (2024)
Wantanee Tommeurd, Kanyarat Thueng-In, Sirin Theerawatanasirikul, Nongnaput Tuyapala, Sukontip Poonsuk, Nantawan Petcharat, Nattarat Thangthamniyom, Porntippa Lekcharoensuk
Identification of Conserved Linear Epitopes on Viral Protein 2 of Foot-and-Mouth Disease Virus Serotype O by Monoclonal Antibodies 6F4.D11.B6 and 8D6.B9.C3. Antibodies (Basel, Switzerland) 13 (3) (2024)
Tsutomu Ishizuka, Kazuhiro Iwadoh, Hiroshi Kataoka, Junichi Hoshino, Kosaku Nitta, Hideki Ishida
Novel Flow Cytometry Method Detecting Complement C1q Bound to Blood Type A/B IgG Antibody for Preventing Severe Antibody-Mediated Rejection in ABO-Incompatible Kidney Transplantation. Antibodies (Basel, Switzerland) 13 (3) (2024)
Ben Niu, Benjamin Lee, Lili Wang, Wen Chen, Jeffrey Johnson
The Accurate Prediction of Antibody Deamidations by Combining High-Throughput Automated Peptide Mapping and Protein Language Model-Based Deep Learning. Antibodies (Basel, Switzerland) 13 (3) (2024)
Felix Stader, Cong Liu, Abdallah Derbalah, Hiroshi Momiji, Xian Pan, Iain Gardner, Masoud Jamei, Armin Sepp
A Physiologically Based Pharmacokinetic Model Relates the Subcutaneous Bioavailability of Monoclonal Antibodies to the Saturation of FcRn-Mediated Recycling in Injection-Site-Draining Lymph Nodes. Antibodies (Basel, Switzerland) 13 (3) (2024)
Wantanee Tommeurd, Kanyarat Thueng-In, Sirin Theerawatanasirikul, Nongnaput Tuyapala, Sukontip Poonsuk, Nantawan Petcharat, Nattarat Thangthamniyom, Porntippa Lekcharoensuk
Identification of Conserved Linear Epitopes on Viral Protein 2 of Foot-and-Mouth Disease Virus Serotype O by Monoclonal Antibodies 6F4.D11.B6 and 8D6.B9.C3. Antibodies (Basel, Switzerland) 13 (3) (2024)
Cinthia Magalhães Rodolphi, Isabela Ferreira Soares, Ada da Silva Matos, Rodrigo Nunes Rodrigues-da-Silva, Marcelo Urbano Ferreira, Lilian Rose Pratt-Riccio, Paulo Renato Rivas Totino, Kézia Katiani Gorza Scopel, Josué da Costa Lima-Junior
Dynamics of IgM and IgG Antibody Response Profile against Linear B-Cell Epitopes from Exoerythrocytic (CelTOS and TRAP) and Erythrocytic (CyRPA) Phases of Plasmodium vivax : Follow-Up Study. Antibodies (Basel, Switzerland) 13 (3) (2024)
Giavanna Paterno, Brenda D Moore, Brach M Bell, Kimberly-Marie M Gorion, Yong Ran, Stefan Prokop, Todd E Golde, Benoit I Giasson
Novel Monoclonal Antibody Specific toward Amyloid-β Binds to a Unique Epitope within the N-Terminal Region. Antibodies (Basel, Switzerland) 13 (3) (2024)
Avi Magid, Khetam Hussein, Halima Dabaja-Younis, Moran Szwarcwort-Cohen, Ronit Almog, Michal Mekel, Avi Weissman, Gila Hyams, Vardit Gepstein, Netanel A Horowitz, Hagar Cohen Saban, Jalal Tarabeia, Michael Halberthal, Yael Shachor-Meyouhas
Knowledge of the Serological Response to the Third BNT162b2 Vaccination May Influence Compliance of Healthcare Workers to Booster Dose. Antibodies (Basel, Switzerland) 13 (3) (2024)
Tonia L Conner, Pooja Vir, Eric D Laing, Ian J Stewart, Edward Mitre, Kathleen P Pratt
The Seraph 100 ® Microbind Affinity Blood Filter Does Not Alter Levels of Circulating or Mucosal Antibodies in Critical COVID-19 Patients. Antibodies (Basel, Switzerland) 13 (3) (2024)
Bok-Nam Park, Young-Sil An, Su-Min Kim, Su-Jin Lee, Yong-Jin Park, Joon-Kee Yoon
177 Lu Anti-Angiogenic Radioimmunotherapy Targeting ATP Synthase in Gastric Cancer Model. Antibodies (Basel, Switzerland) 13 (3) (2024)
Wim H M Vroemen, Shakira S Agata, Joyce J B C van Beers, Jan G M C Damoiseaux
Therapeutic Drug Monitoring of Infliximab and Adalimumab through Concentration and Anti-Drug Antibodies Assessment; Comparison of Sanquin Diagnostics and Theradiag Assays. Antibodies (Basel, Switzerland) 13 (3) (2024)
Ming-Ching Hsieh, Jingming Zhang, Liangjie Tang, Cheng-Yen Huang, Yang Shen, Alice Matathia, Jun Qian, Babita Saxena Parekh
Characterization of the Charge Heterogeneity of a Monoclonal Antibody That Binds to Both Cation Exchange and Anion Exchange Columns under the Same Binding Conditions. Antibodies (Basel, Switzerland) 13 (3) (2024)
Connor Frey, Mahyar Etminan
Immune-Related Adverse Events Associated with Atezolizumab: Insights from Real-World Pharmacovigilance Data. Antibodies (Basel, Switzerland) 13 (3) (2024)
Francesco Ferrara, Chiara Verduci, Emanuela Laconi, Andrea Mangione, Chiara Dondi, Marta Del Vecchio, Veronica Carlevatti, Andrea Zovi, Maurizio Capuozzo, Roberto Langella
Therapeutic Advances in Psoriasis: From Biologics to Emerging Oral Small Molecules. Antibodies (Basel, Switzerland) 13 (3) (2024)
Silvia Zaninelli, Silvia Panna, Sarah Tettamanti, Giusi Melita, Andrea Doni, Francesca D'Autilia, Rut Valgardsdottir, Elisa Gotti, Alessandro Rambaldi, Josee Golay, Martino Introna
Functional Activity of Cytokine-Induced Killer Cells Enhanced by CAR-CD19 Modification or by Soluble Bispecific Antibody Blinatumomab. Antibodies (Basel, Switzerland) 13 (3) (2024)
Monique Vogel, Engeroff Paul
A Comparison of Natural and Therapeutic Anti-IgE Antibodies. Antibodies (Basel, Switzerland) 13 (3) (2024)
Connor Frey, Mahyar Etminan
Adverse Events of PD-1, PD-L1, CTLA-4, and LAG-3 Immune Checkpoint Inhibitors: An Analysis of the FDA Adverse Events Database. Antibodies (Basel, Switzerland) 13 (3) (2024)
Marta Freitas Monteiro, Maria Papaserafeim, Matteo Andreani, Aline Réal, Athanasios Kouklas, Daniela Reis Galvão, Jörg Dieter Seebach, Gisella L Puga Yung
NK Cytotoxicity Mediated by NK-92 Cell Lines Expressing Combinations of Two Allelic Variants for FCGR3 . Antibodies (Basel, Switzerland) 13 (3) (2024)
Ming-Ching Hsieh, Jingming Zhang, Liangjie Tang, Cheng-Yen Huang, Yang Shen, Alice Matathia, Jun Qian, Babita Saxena Parekh
Characterization of the Charge Heterogeneity of a Monoclonal Antibody That Binds to Both Cation Exchange and Anion Exchange Columns under the Same Binding Conditions. Antibodies (Basel, Switzerland) 13 (3) (2024)